SOLAI faces NYSE warning on market cap, equity
SOLAI Limited received an additional notice from the NYSE stating it is not in compliance with continued listing standards because its 30‑day average market capitalization and its stockholders’ equity were each below US$50 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOLAI Limited received an additional notice from the NYSE stating it is not in compliance with continued listing standards because its 30‑day average market capitalization and its stockholders’ equity were each below US$50 million.
The company has 90 days from the April 27, 2026 notice to submit a business plan showing how it will regain compliance within 18 months. Its ADSs remain listed for now but face possible suspension and delisting if the NYSE rejects the plan or if trading levels are deemed “abnormally low,” generally below US$0.10.
SOLAI is already working under a separate NYSE deficiency notice related to maintaining a US$1.00 average share price, and will continue to carry a below‑compliance “.BC” indicator until all standards are met.
Positive
- None.
Negative
- Heightened NYSE delisting risk: SOLAI fell below the NYSE’s US$50 million market capitalization and equity thresholds and is also under a separate US$1.00 share‑price deficiency process, increasing the chance its ADSs could ultimately be suspended or delisted if remediation fails.
Insights
NYSE noncompliance heightens delisting risk for SOLAI’s ADSs.
SOLAI Limited now faces NYSE scrutiny on both market capitalization/equity and minimum share price. The notice cites an average market cap under US$50 million over 30 trading days and stockholders’ equity below US$50 million as of December 31, 2025.
The company has 90 days from April 27, 2026 to present a credible plan to regain compliance within 18 months. Acceptance would trigger quarterly NYSE monitoring; rejection could lead to suspension and SEC delisting proceedings. The NYSE can also accelerate delisting if ADS trading falls below US$0.10, which it views as “abnormally low.”
Although operations and SEC reporting continue unchanged, investors face elevated listing risk while SOLAI develops its remediation plan and works through parallel cure periods for both market‑based and price‑based NYSE standards.
Key Figures
Key Terms
continued listing standards regulatory
market capitalization financial
stockholders’ equity financial
NYSE Listed Company Manual regulatory
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did SOLAI Limited (SLAI) receive a new NYSE noncompliance notice?
How long does SOLAI (SLAI) have to regain NYSE listing compliance?
What happens if the NYSE rejects SOLAI’s SLAI compliance plan?
Does the NYSE notice immediately affect trading of SOLAI (SLAI) ADSs?
When could SOLAI (SLAI) face accelerated NYSE delisting action?
AI-generated analysis. How Rhea-AI works. Not financial advice.